Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Nashville-Davidson-Murfreesboro-Franklin, TN MSA — October 2026
Nashville life sci pay lags national rates in regulatory, clinical roles.
Nashville's Regulatory Affairs Specialist pay sits 13% below the $103,780 national median and Clinical Research Associate pay trails by 24%, even as Research Scientist and Biostatistician compensation climbs locally.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Metro unemployment rate: 2.9% — vs 4.2% national rate, Aug 2026
- CRA pay gap vs. national: -24% — $68,602 metro vs $90,065 national median
- Regulatory Affairs pay gap: -13% — $89,869 metro vs $103,780 national median
- Biopharma quit rate: 1.9% — National rate; experienced staff staying in place
Key takeaways
Nashville's regulatory affairs pay gap is widening.
Metro advertised pay for Regulatory Affairs Specialist fell to $89,869, a 13% discount to the $103,780 national median, even as national commentary identifies regulatory talent as the hardest life sci role to fill in 2026. Compensation strategy built on local benchmarks alone risks losing candidates to remote postings paying national rates.
Biostatistician and Research Scientist pay signal where budget is flowing.
Both roles posted significant increases locally ($137,998 and $133,593) and outpace their national medians, consistent with sustained R&D and analytical investment even as biopharma holds the line on broader headcount growth. Expect continued competition for quantitative talent as a differentiator in hiring strategy.
CRA pay in Nashville trails the national rate by nearly a quarter.
Local CRA advertised pay of $68,602 sits well below the $90,065 national median, a gap that matters given national data shows experienced CRAs are the bottleneck, with entry-level staff in steadier supply. That differential may push clinical operations leaders toward CRO partnerships ahead of building in-house CRA headcount in this market.
CDMO expansion changes the manufacturing talent calculus.
August Bioservices' continued buildout adds high-throughput development and manufacturing capacity in Middle Tennessee, shifting the economics of in-house manufacturing toward outsourcing for lower-volume or specialty programs. Headcount planning for quality and manufacturing functions should account for this shift before committing to internal build-out.
Median advertised pay by role — Nashville-Davidson-Murfreesboro-Franklin, TN MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $120,640 | $133,593 | $145,080 | Significant increase | $130,339 |
| Clinical Research Associate | $58,008 | $68,602 | $103,134 | Moderate increase | $90,065 |
| Lab Technician | $44,257 | $44,798 | $47,572 | Significant decline | $47,840 |
| Regulatory Affairs Specialist | $81,590 | $89,869 | $110,379 | Moderate decline | $103,780 |
| Clinical Data Manager * | $95,084 | $104,652 | $110,324 | Moderate decline | $123,653 |
| Biostatistician | $96,456 | $137,998 | $138,344 | Significant increase | $131,958 |
| Validation Engineer * | $95,603 | $105,499 | $112,797 | Moderate increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Nashville's 2.9% metro unemployment rate sits 130 basis points below the national 4.2%, and nonfarm job growth of 28,400 over the past year has concentrated in healthcare and social assistance alongside leisure and state government, leaving specialized scientific and clinical functions to compete against broad-based labor tightness across the metro economy. August Bioservices' continued Middle Tennessee development adds CDMO capacity precisely as biopharma nationally reports a 1.9% quit rate, meaning experienced talent is staying put while employer demand for regulatory, clinical operations, and biomanufacturing expertise keeps climbing.
What it means
Metro advertised pay for Clinical Research Associate ($68,602) and Regulatory Affairs Specialist ($89,869) trail national medians by 24% and 13% respectively, a gap that complicates recruiting against remote or hybrid roles tied to national rates and raises the stakes on build-vs-outsource calculus as CRO/CDMO capacity (including August Bioservices) expands locally. Research Scientist and Biostatistician pay moving up significantly in Nashville while Clinical Data Manager and Regulatory Affairs fall suggests budget is concentrating toward data-generation and analytical roles ahead of compliance and operations functions. Organizations should evaluate whether regulatory and clinical operations compensation has fallen out of step with the premium those roles command nationally before losing scarce talent to employers paying closer to the $103,780 national regulatory affairs median.
Looking ahead
Worth watching: August Bioservices' capacity additions could absorb a meaningful share of Middle Tennessee's biomanufacturing and quality talent pool over the next two quarters. Monitor whether this tightens competition for validation engineers and bioprocess specialists already seeing moderate advertised pay growth locally ($105,499).
Emerging pressure point: Regulatory Affairs and Clinical Data Manager advertised pay both declined locally this month while national rates held stable or fell more modestly, widening the metro-to-national gap. Watch whether this spread triggers visible attrition toward remote-eligible postings before year-end.
Early indicator: Tennessee's life, physical, and social science occupations are projected to grow 8.6% by the state's own workforce estimates, with earnings nearly doubling from entry to senior levels. Track whether entry and mid-career compression in Nashville specifically becomes a retention risk as that growth materializes.
Potential inflection point: National biopharma hiring sentiment shows 41% of organizations expecting more open roles in 2026 despite a 1.9% quit rate holding experienced talent in place. If Nashville's CDMO and CRO capacity continues expanding, watch for early signs of wage acceleration in specialized manufacturing and clinical operations roles that have lagged nationally.
Sources
- Cushman & Wakefield Nashville MarketBeat Q3 2026 — Nashville metro unemployment rate and comparison to national rate
- Nashville Banner — Nonfarm job growth of 28,400 concentrated in healthcare, leisure, state government
- Tennessee Life Sciences Labor Market Research Notes — August Bioservices CDMO development in Middle Tennessee
- Life Sciences Industry Workforce Survey — Experienced CRAs identified as bottleneck in national clinical talent market
- Life Sciences Industry Workforce Survey — Regulatory affairs, clinical operations, CMC cited as hardest roles to fill in 2026
- Biopharma Industry Labor Market Survey — Biopharma national quit rate of 1.9% amid active recruiting
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.